All data are based on the daily closing price as of November 18, 2026
c
Center Laboratories
4123.TWO
0.82 USD
-0.02
-2.38%
Overview
Last close
0.82 usd
Market cap
646.07M usd
52 week high
1.56 usd
52 week low
0.82 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
2500
Price/Sales
13.1274
Price/Book Value
1.3205
Enterprise Value
731.47M usd
EV/Revenue
13.5431
EV/EBITDA
11.5251
Key financials
Revenue TTM
50.31M usd
Gross Profit TTM
21.77M usd
EBITDA TTM
6.76M usd
Earnings per Share
-0.08 usd
Dividend
N/A usd
Total assets
702.94M usd
Net debt
99.05M usd
About
Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also provides central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei, Taiwan.